Sponsor or institution
Clinical trials and research at Changzhou No.2 People's Hospital
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Changzhou No.2 People's Hospital that are recruiting, in China. By phase: Phase 2 (2), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Public attitudes about gallbladder-preserving lithotomy | — | Changzhou, Jiangsu | Recruiting | Oct 2, 2026 |
| Using multimedia health education to reduce anxiety in patients with vitreous floaters | — | Changzhou, Jiangsu | Recruiting | May 11, 2025 |
| Fecal transplant plus QL1706, bevacizumab, and XELOX as first-line treatment for advanced MSS colon cancer with liver metastases | Phase 2 | Changzhou | Recruiting | Jan 30, 2025 |
| Using Fecal Microbiota Transplantation with Chemotherapy and Immunotherapy for Advanced Gastric Cancer | Phase 2 | Changzhou | Recruiting | May 8, 2024 |
| Using CD19 CAR NK cells to treat refractory immune thrombocytopenia | Early Phase 1 | Changzhou, Jiangsu | Recruiting | Mar 29, 2024 |
All recruiting trials (5)
-
Public attitudes about gallbladder-preserving lithotomy
This study tests what people think about trying to preserve the gallbladder during gallstone treatment, by asking questions to patients and the public in Changzhou, China.
-
Using multimedia health education to reduce anxiety in patients with vitreous floaters
This study tests if using multimedia health education can help reduce anxiety in patients dealing with vitreous floaters compared to traditional education methods.
-
Fecal transplant plus QL1706, bevacizumab, and XELOX as first-line treatment for advanced MSS colon cancer with liver metastases
This trial will test whether giving a fecal microbiota transplant before combined QL1706, bevacizumab, and XELOX chemotherapy helps adults with untreated advanced MSS colon cancer that has spread to the liver.
-
Using Fecal Microbiota Transplantation with Chemotherapy and Immunotherapy for Advanced Gastric Cancer
This study is testing if adding a fecal microbiota transplant to chemotherapy and immunotherapy helps people with advanced gastric cancer live longer and feel better.
-
Using CD19 CAR NK cells to treat refractory immune thrombocytopenia
This study is testing a new treatment using special immune cells to see if it can help people with a tough-to-treat blood condition called refractory immune thrombocytopenia.
Quick answers
How many clinical trials run by Changzhou No.2 People's Hospital are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.